Data monitoring committees (DMCs) play a critical role in ensuring the ethical conduct of clinical trials. Data monitoring committee charters set out the role and processes for data monitoring committees in monitoring clinical trials; however, little is known about the information that DMC charters contain. In this webinar, we will share results of an exploratory analysis of DMC charters, drawing out ethically and practically pertinent issues. These will be considered in light of findings from our broader project on ethical challenges faced by DMCs.
Presenters

Dr Lisa Eckstein is the CT:IQ Director and Ethics Specialist for Bellberry Ltd. She is an adjunct Senior Lecturer in the Faculty of Law at the University of Tasmania, where her research focuses on the regulation of clinical trials, genomic privacy, and consent.

Prof Seema K. Shah, JD, HEC-C, focuses on the question of when it is ethically and legally acceptable to expose some people to risk to benefit others. Her research has analyzed this question in pediatric, infectious disease, and global health research, as well as in the determination of death. Professor Shah is the Director of the Pediatric Research Ethics and Policy Program and the Director of Research Ethics at Ann & Robert H. Lurie Children’s Hospital of Chicago. She is an Associate Professor of Pediatrics at Lurie Children’s and Northwestern University Feinberg School of Medicine, and holds a courtesy appointment at Northwestern University Pritzker School of Law.
Latest Resources
-
-
ACTA STInG Webinar: The target trial framework for causal inference: a primer
-
Adaptive Allies: The Evolving Roles of DSMBs and Investigators in Bayesian Platform Trials – Part 3
-
The challenges of stopping trials for benefit: Lessons learnt from the immediate Kangaroo Mother Care (iKMC) trial – Part 2
-
STInG Chat – What makes this trial great?
-
Platform trials: key features, when to use them and methodological challenges
-
Interim Data Sharing by Data Safety Monitoring Board: What to share, with whom, and why – Part 1
-
Data Integrity Tool for assessing the integrity of randomised trials
-
The value of getting involved with ACTA STInG
-
Winner of the ACTA STInG Excellence in Trial Statistics award shares how ACTA STInG provided valuable networking opportunities during the pandemic
-
Data and Safety Monitoring Board (DSMB) Mentoring Program
-
ACTA Webinar – Developing a Best Practice Guide for Registry Based Trials
Latest Events
-
ACTA webinar: Tackling dichotomania (p<0.05) and other statistical diseases in pursuit of better science
-
ACTA 2026 Trial of the Year Awards Ceremony
-
ACTA STInG Webinar: The target trial framework for causal inference: a primer
-
STInG Chat – What makes this trial great?
-
ACTA 2025 Clinical Trials and Registries Symposium
-
ACTA Webinar – Data Integrity Tool for assessing the integrity of randomised trials
-
ACTA Webinar – Developing a Best Practice Guide for Registry Based Trials
-
STInG Chat – How to build a career as a clinical trials biostatistician
-
Good Statistical Practice – GCP training for statisticians
-
ACTA – Historical and non-concurrent controls in clinical trials
-
STInG Chat: ‘Securing Funding: Tips and Tricks for Investigator Grants’